Keyphrases
Breast Cancer Patients
100%
Triple-negative Breast Cancer
100%
Patient-derived Xenograft
100%
Proteomics
100%
Resistance Biomarkers
100%
PI3K Inhibitor
100%
PI3K Pathway
75%
BKM120
50%
Tumor Growth Response
50%
KLF4
25%
Antitumor Activity
25%
Phosphorylated Forms
25%
Growth Hormone Receptor
25%
PTEN Loss
25%
Akt Phosphorylation
25%
Tumor Inhibition
25%
Biomarker Development
25%
Anti-apoptotic Proteins
25%
Matrix metalloproteinase-9 (MMP-9)
25%
Pathway Activation
25%
Signaling Activity
25%
Response Mechanism
25%
Pathway Activity
25%
Regulatory Subunit
25%
Vimentin
25%
Resistance Mechanisms
25%
Intracellular Signaling Molecules
25%
Protein Markers
25%
Caveolin
25%
Biomarkers of Response
25%
Phosphorylated Akt
25%
Pathway Signaling
25%
Genomic Background
25%
Patient-derived Tumor Xenograft
25%
Aurora Kinase A (AURKA)
25%
RANKL Signaling
25%
Reverse Phase Protein Array
25%
IkappaB
25%
PI3K-p85
25%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Proteomics
100%
Antineoplastic Activity
33%
Epidermal Growth Factor Receptor
33%
Genetic Background
33%
Growth Inhibition
33%
Gelatinase B
33%
MMP9
33%
Vimentin
33%
RANKL
33%
Growth Factor Receptor
33%
Protein Microarray
33%
Intracellular Signaling
33%
Caveolin
33%
Aurora Kinase
33%
KLF4
33%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Biological Marker
100%
Neoplasm
50%
Tumor Growth
50%
Buparlisib
50%
Antiapoptotic
25%
Epidermal Growth Factor Receptor
25%
Growth Factor Receptor
25%
Cancer Inhibition
25%
Gelatinase B
25%
Osteoclast Differentiation Factor
25%
Vimentin
25%
Kruppel Like Factor 4
25%
Aurora Kinase
25%
Caveolin
25%